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A simple protocol for the synthesis of 2-amino-1,3,4-oxadiazoles starting from the corresponding acy-
lhydrazides by cyclodesulfurization of intermediate acylthiosemicarbazides mediated by o-iodoxyben-
zoic acid in good yields has been described. The protocol is mild with wide substrate scope, and thus a
range of 2-amino-1,3,4-oxadiazoles have been prepared.
 2012 Elsevier Ltd. All rights reserved.1,3,4-Oxadiazoles have found extensive use as pharmacophores
due to their metabolic proﬁle and ability to engage in hydrogen
bonding. 2-Amino-1,3,4-oxadiazoles have a wide range of biologi-
cal activities such as antimicrobial agents, anti-inﬂammatory
agents, anticancer agents, muscle relaxants, and antimitotics,1
the 2,5-diaryl-1,3,4-oxadiazoles are known to be platelet aggrega-
tion inhibitors.2 Due to myriad of biological applications of 1,3,4-
oxadiazole scaffolds, efﬁcient and mild methods to synthesize
these moieties have attracted considerable interest. Our research
group has recently reported simple access to 2-amino-1,3,4-oxadi-
azole peptidomimetics using p-TsCl mediated cyclization of amino
acid derived thiosemicarbazides.3 The most commonly followed
strategy involves cyclization of the corresponding acyclic semi-
carbazide4 (X = O) or thiosemicarbazide derivatives5 (X = S),
(Scheme 1). The reported protocols in the literature involve two
steps, wherein semicarbazide/acylthiosemicarbazides were syn-
thesized by reaction of hydrazides with the requisite isocyanate/
isothiocyanate, which is typically isolated and puriﬁed. In the fol-
lowing step, cyclization was carried out using an appropriate re-
agent. Most of these methods have several disadvantages such as
handling of harsh and toxic reagents, elevated temperatures, long
reaction time etc. Xie et al. has recently described an efﬁcient cyc-
lodeselenization by heating selenosemicarbazides (X = Se) in DMF
in one-pot from isoselenocyanates and hydrazides,6 resulting in
high yields of 2-amino-1,3,4-oxadiazoles. This protocol is devoid
of the usage of any deselenizing reagent. Also there are a fewll rights reserved.
6312937.
abuvommina@rediffmail.comreports wherein one pot strategy was explored starting from
acylhydrazides using p-TsCl/pyridine5a and PS-carbodiimide7 and
both these methods suffer from harsh conditions which require
heating for long hours for the cyclization of the acylthiosemicar-
bazide intermediate. Thus newer and mild protocols for this privi-
leged class of molecules are continuously sought. In quest of novel
methodologies for heterocycles, we have now focused on a simple
and efﬁcient protocol for the synthesis of 2-amino-1,3,4-
oxadiazoles.
Hypervalent iodine reagents have been extensively used in var-
ious organic transformations because of their mild oxidizing and
environmentally benign nature. The iodine atom in hypervalent
iodine(V) reagents has strong electrophilic character and with
the leaving ability of the phenyliodino group makes them reagents
of choice for various oxidative transformations.8 In addition, their
afﬁnity for sulfur has made these reagents attractive alternatives
for desulfurization instead of heavy metal reagents.9 Recently, an
efﬁcient synthesis of carbodiimides has been reported by desulfur-
ization of thioureas using a variety of hypervalent iodine
reagents.9d,e We envisaged the use of o-iodoxybenzoic acid10
(IBX) as oxidative cyclization agent in the synthesis of 2-amino-
1,3,4-oxadiazoles through a possible carbodiimide intermediate.
On reviewing the mechanism of IBX oxidations, we presumed that
cyclization of semicarbazide would generate water as possible side
product, in which case the carbodiimide intermediate will revert
back to the starting semicarbazide. Whereas in case of thiosemi-
carbazide it may result in efﬁcient cyclization with precipitation
of elemental sulfur.9 Similar would be the case for selenosemicar-
bazide, wherein cyclodeselenization using IBXmay result in 2-ami-
no-1,3,4-oxadiazole with the precipitation of elemental selenium.
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Scheme 1. Two step strategies for the preparation of 2-amino-1,3,4-oxadiazoles.
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Scheme 3. Plausible mechanism for the formation of 2-amino-1,3,4-oxadiazole 4
from thiosemicarbazide 3.
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Scheme 2. One pot synthesis of 2-amino-1,3,4-oxadiazoles.
Table 1
List of 2-amino-1,3,4-oxadiazoles prepared
Entry Hydrazide
(1) R1
Isothiocyanate
(2) R2
Product (4) Yielda
(%)
a C6H5 C6H5
NN
O NH
92
b 2-CH3C6H4 C6H5
NN
O NH
86
c 3-NO2C6H4 C6H5
NN
O NHO2N
85
d 4-CH3OC6H4 C6H5
NN
O NHH3CO
83
e 2-ClC6H4 C6H5
NN
O NH
Cl
84
f 3-C4H4N C6H5
NN
O NHN
83
g 4-C4H4N C6H5
NN
O NHN
86
h C6H5 C6H5CH2
NN
O NH
84
i C6H5 C6H11
NN
O NH
82
j C6H5 C4H9
NN
O NH
80
k C6H5CH2 C6H5CH2
NN
O NH
86
l C6H5CH2 C6H11
NN
O NH
84
m C6H5CH2 C6H5
NN
O NH
88
a Isolated yield.
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acylthiosemicarbazide, to obtain 2-amino-1,3,4-oxadiazoles. Weenvisioned that due to the polarizability of sulfur and thiophilic
nature of hypervalent iodine reagents, thiosemicarbazide could
be activated by IBX affording an intermediate which is more prone
toward cyclization (Scheme 2) and consequently we employed this
strategy for one pot synthesis of 2-amino-1,3,4-oxadiazoles di-
rectly from acylhydrazides.
In a typical reaction, phenylisothiocyanate 1b was treated with
benzoylhydrazide 1a in CH2Cl2 at rt. After completion of reaction
(by TLC), the intermediate acylthiosemicarbazide was directly
treated with triethylamine (TEA, 2 equiv) and IBX (1 equiv) added
portion wise with continued stirring. Gratifyingly, within 15 min
the required oxadiazole was formed in 92% isolated yield.11 The
reaction conditions were optimized with respect to solvents such
as DMF, MeCN, EtOAc, THF, and equivalents of IBX and TEA. How-
ever, molar ratio of 1:1:2 for substrate/IBX/TEA in CH2Cl2 as solvent
was found to be efﬁcient and cleaner. Lesser equivalents of TEA re-
sulted in lower yield of ﬁnal product. These results encouraged us
to examine the generality of this protocol. Thus, a variety of acy-
lhydrazides and isothiocyanates were subjected to the afore-men-
tioned protocol (Table 1). In all cases complete conversion to
amino oxadiazoles in good yields and purity was obtained under
very mild conditions (Table 1, entries a–m).
In analogy with the literature reports of desulfurization by
hypervalent iodine reagents,9 the following mechanism (Scheme
3) was proposed for the cyclodesulfurization of acylthiosemicar-
bazides by IBX. Initially the nucleophilic attack of S on the electro-
philic iodine of IBX will form intermediate A. Then TEA assisted
desulfurization (path a) leads to carbodiimide intermediate B and
subsequent cyclization resulting in 2-amino-1,3,4-oxadiazole. In
a second pathway b, cyclization may be effected by direct nucleo-
philic attack by carbonyl oxygen assisted by TEA. The precipitation
of elemental sulfur supports the proposed mechanism.
The generality of methodology has further been demonstrated
by an example of cyclodeselenization of intermediate acylsele-
nosemicarbazide, wherein the optimized conditions were tested
for N-phenylisoselenocyanate and benzoylhydrazide 1a in CH2Cl2
at rt in one pot. As expected, cyclodeselenization was found to be
4234 G. Prabhu, V. V. Sureshbabu / Tetrahedron Letters 53 (2012) 4232–4234complete within 10 min of the addition of IBX, giving same product
4a. The yield was comparable to that of cyclodesulfurization at 91%
and thus, this protocol can be extended to other substrates as well.
Hence, it was evident that the IBX reagent works efﬁciently for
cyclodelfurization/cyclodeselenization resulting in required 2-ami-
no-1,3,4-oxadizoles in good yields and purity.
In summary, the present methodology provides a robust one-
pot approach for efﬁcient preparation of a variety of 2-amino-
1,3,4-oxadiazoles in good yields. Important feature of this method-
ology is that the acylthiosemicarbazides were prepared in situ and
subjected to subsequent cyclization without puriﬁcation using IBX
within a short duration of time, thus resulting in a hassle-free and
convenient one-pot synthesis. Thus, this strategy provides rapid
access to a wide variety of 2-amino-1,3,4-oxadiazoles under mild
conditions at room temperature.
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Na2SO4, which was then admixed with silica gel and subjected to column
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